Commonwealth Coat of Arms of Australia

National Health (Pharmaceutical benefits—early supply) Instrument 2015

PB 120 of 2015

made under subsection 84AAA(2) of the

National Health Act 1953

Compilation No. 89

Compilation date: 1 March 2024

Includes amendments: F2024L00238

Registered: 8 March 2024

About this compilation

This compilation

This is a compilation of the National Health (Pharmaceutical benefits—early supply) Instrument 2015 that shows the text of the law as amended and in force on 1 March 2024 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

 

 

 

Contents

1 Name of Instrument

4 Definitions

5 Specification of pharmaceutical items

6 Circumstances relating to specification of pharmaceutical items in Schedule 1

7 Circumstances relating to specification of pharmaceutical items in Schedule 2

8 Specification of period relating to a pharmaceutical benefit

Schedule 1—Pharmaceutical items and circumstances specified under subsection 84AAA(2) for purposes of early supply

Schedule 2—Pharmaceutical items and circumstances specified under subsection 84AAA(2) for purposes of early supply– increased maximum quantity or number of units

Endnotes

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

1  Name of Instrument

 (1) This Instrument is the National Health (Pharmaceutical benefits—early supply) Instrument 2015.

 (2) This Instrument may also be cited as PB 120 of 2015.

4  Definitions

 (1) In this Instrument:

Act means the National Health Act 1953.

g means grams.

I.U. means international unit.

mg means milligram.

mL means millilitre.

pharmaceutical benefit has the meaning given by section 84 of the Act.

pharmaceutical item has the meaning given by section 84AB of the Act.

purposes code has the same meaning as in the National Health (Listing of Pharmaceutical Benefits) Instrument 2012.

relevant previous supply means the most recent previous supply to a person of:

 (a) the same pharmaceutical benefit; or

 (b) another pharmaceutical benefit that has the same pharmaceutical item as the pharmaceutical benefit; or

 (c) another pharmaceutical benefit that is Schedule equivalent to the pharmaceutical benefit.

relevant purpose, for a pharmaceutical benefit, means a purpose, mentioned in Schedule 4 of the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 for a purposes code specified in Schedule 1 of that instrument for the pharmaceutical benefit, that includes the phrase “The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient”.

Schedule equivalent has the same meaning as in Part VII of the Act.

 (2) A reference in this instrument to supply on the basis of a prescription includes reference to supply on the basis of a repeat authorisation or deferred supply authorisation.

5  Specification of pharmaceutical items

 (1) A pharmaceutical item in a pharmaceutical benefit is specified for paragraph 84AAA(1)(a) of the Act if subsection (2) or (3) applies in relation to the pharmaceutical item.

 (2) This subsection applies if:

 (a) the listed drug and the form of that listed drug in the pharmaceutical item are mentioned in the table in Schedule 1; and

 (b) all the circumstances identified in section 6 exist in relation to a benefit that has the listed drug and form in the table in Schedule 1.

 (3) This subsection applies if:

 (a) the listed drug and the form of that listed drug in the pharmaceutical item are mentioned in the table in Schedule 2; and

 (b) all the circumstances identified in section 7 exist in relation to a pharmaceutical benefit that has the listed drug and form in the table in Schedule 2.

Note: All pharmaceutical items have a manner of administration determined under subsection 85(5) of the Act, so the listed drug in that form with that manner of administration is specified.

6  Circumstances relating to specification of pharmaceutical items in Schedule 1

 (1) For paragraph 5(2)(b), the circumstances are as follows:

 (a) the form mentioned in the table in Schedule 1 of a pharmaceutical benefit that has the listed drug is the same as the form determined under subsection 85(3) of the Act;

 (b) a maximum quantity or number of units mentioned in the table in Schedule 1 for a benefit that has the listed drug and form is the same as a maximum quantity or number of units determined under paragraph 85A(2)(a) of the Act;

 (c) a maximum number of repeats mentioned in the table in Schedule 1 for a benefit that has the listed drug and form is the same as a maximum number of repeats determined under paragraph 85A(2)(b) of the Act;

 (d) where the supply of the pharmaceutical benefit was made on the basis of a prescription  ̶  the quantity or number of units of the pharmaceutical benefit directed to be supplied on any one occasion in the prescription was not directed for a relevant purpose for the pharmaceutical benefit; and

 (e) any other circumstance for paragraph 84AAA(3)(b) of the Act that is mentioned in the table in Schedule 1 for a benefit that has the listed drug and form.

7  Circumstances relating to specification of pharmaceutical items in Schedule 2

 (1) For paragraph 5(3)(b), the circumstances are as follows:

 (a) the form mentioned in the table in Schedule 2 of a pharmaceutical benefit that has the listed drug is the same as the form determined under subsection 85(3) of the Act;

 (b) a maximum quantity or number of units mentioned in the table in Schedule 2 for a benefit that has the listed drug and form is the same as a maximum quantity or number of units determined under paragraph 85A(2)(a) of the Act;

 (c) a maximum number of repeats mentioned in the table in Schedule 2 for a pharmaceutical benefit that has the listed drug and form is the same as a maximum number of repeats determined under paragraph 85A(2)(b) of the Act;

 (d) the pharmaceutical benefit was supplied on the basis of a prescription;

 (e) the quantity or number of units of the pharmaceutical benefit directed to be supplied on any one occasion in the prescription was directed for a relevant purpose for the pharmaceutical benefit; and

 (f) any other circumstance for paragraph 84AAA(3)(b) of the Act that is mentioned in the table in Schedule 2 for a benefit that has the listed drug and form.

8  Specification of period relating to a pharmaceutical benefit

 (1) This section is made for paragraph 84AAA(1)(b) of the Act.

 (2) For a pharmaceutical benefit that has the listed drug and the form of the listed drug mentioned in the table in Schedule 1, and the circumstances identified for section 6 apply, the number mentioned under the heading ‘Period’ in the table in Schedule 1 for the listed drug and form is the period in days.

 (3) For a pharmaceutical benefit that has the listed drug and the form of the listed drug mentioned in the table in Schedule 2, and the circumstances identified for section 7 apply:

 (a) where the relevant previous supply to the person was on the basis of a prescription and the quantity or number of units of the pharmaceutical benefit directed to be supplied on any one occasion in the prescription was directed for a relevant purpose for the previously supplied pharmaceutical benefit – the number mentioned under the heading ‘Period’ for the listed drug and form is the period in days;

 (b) in any other case – the period is 20 days.

Schedule 1—Pharmaceutical items and circumstances specified under subsection 84AAA(2) for purposes of early supply

 

Listed drug

Form

Period

(days)

Circumstances:

Maximum quantity or number of units

Maximum number of repeats

Other circumstances (if any)

Abatacept

Injection 125 mg in 1 mL single dose autoinjector

20

4

5

 

 

Injection 125 mg in 1 mL single dose pre‑filled syringe

20

4

5

 

Abemaciclib

Tablet 50 mg

20

56

5

 

 

Tablet 100 mg

20

56

5

 

 

Tablet 150 mg

20

56

5

 

Abiraterone

Tablet containing abiraterone acetate 250 mg

20

120

2

 

 

Tablet containing abiraterone acetate 500 mg

20

60

2

 

Acalabrutinib

Capsule 100 mg

20

56

5

 

 

Tablet 100 mg

20

56

5

 

 

 

20

56

6

 

Aciclovir

Tablet 200 mg

20

90

5

 

Aclidinium

Powder for oral inhalation in breath actuated device 322 micrograms (as bromide) per dose, 60 doses

20

1

5

 

Aclidinium with formoterol

Powder for oral inhalation in breath actuated device containing aclidinium 340 micrograms (as bromide) with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses

20

1

5

 

Adalimumab

Injection 20 mg in 0.2 mL pre‑filled syringe

20

2

0

 

 

 

20

2

3

 

 

 

20

2

5

 

 

Injection 20 mg in 0.4 mL pre‑filled syringe

20

2

0

 

 

 

20

2

3

 

 

 

20

2

5

 

 

Injection 40 mg in 0.4 mL pre‑filled pen

20

2

0

 

 

 

20

2

2

 

 

 

20

2

5

 

 

 

20

4

5

 

 

 

20

6

0

 

 

Injection 40 mg in 0.4 mL pre‑filled syringe

20

2

0

 

 

 

20

2

2

 

 

 

20

2

5

 

 

 

20

6

0

 

 

Injection 40 mg in 0.8 mL pre‑filled pen

20

2

0

 

 

 

20

2

2

 

 

 

20

2

5

 

 

 

20

4

5

 

 

 

20

6

0

 

 

Injection 40 mg in 0.8 mL pre‑filled syringe

20

2

0

 

 

 

20

2

2

 

 

 

20

2

5

 

 

 

20

6

0

 

 

Injection 80 mg in 0.8 mL pre‑filled pen

20

2

5

 

 

 

20

3

0

 

 

Injection 80 mg in 0.8 mL pre‑filled syringe

20

2

5

 

 

 

20

3

0

 

Alendronic acid

Tablet 70 mg (as alendronate sodium)

20

4

5

 

Alendronic acid with colecalciferol

Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol

20

4

5

 

 

Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol

20

4

5

 

Alirocumab

Injection 75 mg in 1 mL single use pre‑filled pen

20

2

5

 

 

Injection 150 mg in 1 mL single use pre‑filled pen

20

2

5

 

Allopurinol

Tablet 100 mg

20

200

2

 

 

Tablet 300 mg

20

60

2

 

Alogliptin

Tablet 6.25 mg (as benzoate)

20

28

5

 

 

Tablet 12.5 mg (as benzoate)

20

28

5

 

 

Tablet 25 mg (as benzoate)

20

28

5

 

Alogliptin with metformin

Tablet containing 12.5 mg alogliptin (as benzoate) with 500 mg metformin hydrochloride

20

56

5

 

 

Tablet containing 12.5 mg alogliptin (as benzoate) with 850 mg metformin hydrochloride

20

56

5

 

 

Tablet containing 12.5 mg alogliptin (as benzoate) with 1 g metformin hydrochloride

20

56

5

 

Amantadine

Capsule containing amantadine hydrochloride 100 mg

20

100

5

 

Amifampridine

Tablet 10 mg

20

200

5

 

Amlodipine

Tablet 5 mg (as besilate)

20

30

5

 

 

Tablet 10 mg (as besilate)

20

30

5

 

Amlodipine with atorvastatin

Tablet 5 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium)

20

30

5

 

 

Tablet 5 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium)

20

30

5

 

 

Tablet 5 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium)

20

30

5

 

 

Tablet 5 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium)

20

30

5

 

 

Tablet 10 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium)

20

30

5

 

 

Tablet 10 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium)

20

30

5

 

 

Tablet 10 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium)

20

30

5

 

 

Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium)

20

30

5

 

Amlodipine with valsartan

Tablet 5 mg (as besilate)‑80 mg

20

28

5

 

 

Tablet 5 mg (as besilate)‑160 mg

20

28

5

 

 

Tablet 5 mg (as besilate)‑320 mg

20

28

5

 

 

Tablet 10 mg (as besilate)‑160 mg

20

28

5

 

 

Tablet 10 mg (as besilate)‑320 mg

20

28

5

 

Amlodipine with valsartan and hydrochlorothiazide

Tablet 5 mg (as besilate)‑160 mg‑12.5 mg

20

28

5

 

 

Tablet 5 mg (as besilate)‑160 mg‑25 mg

20

28

5

 

 

Tablet 10 mg (as besilate)‑160 mg‑12.5 mg

20

28

5

 

 

Tablet 10 mg (as besilate)‑160 mg‑25 mg

20

28

5

 

 

Tablet 10 mg (as besilate)‑320 mg‑25 mg

20

28

5

 

Anastrozole

Tablet 1 mg

20

30

5

 

Apalutamide

Tablet 60 mg

20

120

5

 

Apixaban

Tablet 2.5 mg

20

60

0

 

 

 

20

60

5

 

 

Tablet 5 mg

20

28

0

 

 

 

20

60

5

 

Armodafinil

Tablet 50 mg

20

60

5

 

 

Tablet 150 mg

20

30

5

 

 

Tablet 250 mg

20

30

5

 

Asciminib

Tablet 20 mg

20

60

5

 

 

Tablet 40 mg

20

60

5

 

 

 

20

300

5

 

Aspirin

Tablet 100 mg

20

112

1

 

Atazanavir with cobicistat

Tablet containing 300 mg atazanavir and 150 mg cobicistat

20

60

5

 

Atenolol

Oral solution 50 mg in 10 mL, 300 mL

20

1

5

 

 

Tablet 50 mg

20

30

5

 

Atomoxetine

Capsule 10 mg (as hydrochloride)

20

56

5

 

 

Capsule 18 mg (as hydrochloride)

20

56

5

 

 

Capsule 25 mg (as hydrochloride)

20

56

5

 

 

Capsule 40 mg (as hydrochloride)

20

56

5

 

 

Capsule 60 mg (as hydrochloride)

20

56

5

 

 

Capsule 80 mg (as hydrochloride)

20

28

5

 

 

Capsule 100 mg (as hydrochloride)

20

28

5

 

Atorvastatin

Tablet 10 mg (as calcium)

20

30

5

 

 

 

20

30

11

 

 

Tablet 20 mg (as calcium)

20

30

5

 

 

 

20

30

11

 

 

Tablet 40 mg (as calcium)

20

30

5

 

 

 

20

30

11

 

 

Tablet 80 mg (as calcium)

20

30

5

 

 

 

20

30

11

 

Auranofin

Capsule 3 mg

20

60

5

 

 

Tablet 3 mg

20

60

5

 

Azacitidine

Tablet 200 mg

20

14

2

 

 

Tablet 300 mg

20

14

2

 

 

 

20

21

1

 

Azathioprine

Tablet 25 mg

20

100

5

 

 

Tablet 50 mg

20

100

5

 

Baclofen

Tablet 10 mg

20

100

5

 

 

Tablet 25 mg

20

100

5

 

Balsalazide

Capsule containing balsalazide sodium 750 mg

20

280

5

 

Baricitinib

Tablet 2 mg

20

28

5

 

 

Tablet 4 mg

20

28

5

 

Beclometasone with formoterol and glycopyrronium

Pressurised inhalation containing beclometasone dipropionate 100 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses

20

1

5

 

 

Pressurised inhalation containing beclometasone dipropionate 200 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses

20

1

5

 

Betaine

Oral powder 180 g

20

1

5

 

Betamethasone

Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL

20

5

0

 

Bicalutamide

Tablet 50 mg

20

28

5

 

Bictegravir with emtricitabine with tenofovir alafenamide

Tablet containing bictegravir 50 mg with emtricitabine 200 mg with tenofovir alafenamide 25 mg

20

60

5

 

Bimekizumab

Injection 160 mg in 1 mL single use pre‑filled pen

20

2

2

 

 

 

20

2

4

 

Bisoprolol

Tablet containing bisoprolol fumarate 2.5 mg

20

28

5

 

 

Tablet containing bisoprolol fumarate 5 mg

20

28

5

 

 

Tablet containing bisoprolol fumarate 10 mg

20

28

5

 

Brexpiprazole

Tablet 1 mg

20

30

0

 

 

Tablet 2 mg

20

30

5

 

 

Tablet 3 mg

20

30

5

 

 

Tablet 4 mg

20

30

5

 

Brivaracetam

Oral solution 10 mg per mL, 300 mL

20

1

5

 

 

Tablet 25 mg

20

56

5

 

 

Tablet 50 mg

20

56

5

 

 

Tablet 75 mg

20

56

5

 

 

Tablet 100 mg

20

56

5

 

Budesonide with glycopyrronium and formoterol

Pressurised inhalation containing budesonide 160 micrograms with glycopyrronium 7.2 micrograms and formoterol fumarate dihydrate 5 micrograms per dose, 120 doses

20

1

5

 

Buprenorphine

Injection (modified release) 8 mg in 0.16 mL pre‑filled syringe

20

4

2

 

 

Injection (modified release) 16 mg in 0.32 mL pre‑filled syringe

20

4

2

 

 

Injection (modified release) 24 mg in 0.48 mL pre‑filled syringe

20

4

2

 

 

Injection (modified release) 32 mg in 0.64 mL pre‑filled syringe

20

4

2

 

 

Injection (modified release) 64 mg in 0.18 mL pre‑filled syringe

20

1

2

 

 

Injection (modified release) 96 mg in 0.27 mL pre‑filled syringe

20

1

2

 

 

Injection (modified release) 100 mg in 0.5 mL pre‑filled syringe

20

1

2

 

 

Injection (modified release) 128 mg in 0.36 mL pre‑filled syringe

20

1

2

 

 

Injection (modified release) 160 mg in 0.45 mL pre‑filled syringe

20

1

2

 

 

Injection (modified release) 300 mg in 1.5 mL pre‑filled syringe

20

1

2

 

 

Tablet (sublingual) 400 micrograms (as hydrochloride)

20

28

2

 

 

Tablet (sublingual) 2 mg (as hydrochloride)

20

84

2

 

 

Tablet (sublingual) 8 mg (as hydrochloride)

20

112

2

 

Buprenorphine with naloxone

Film (soluble) 2 mg (as hydrochloride)‑0.5 mg (as hydrochloride)

20

84

2

 

 

Film (soluble) 8 mg (as hydrochloride)‑2 mg (as hydrochloride)

20

112

2

 

Bupropion

Tablet containing bupropion hydrochloride 150 mg (sustained release)

20

30

0

 

 

 

20

90

0

 

Cabergoline

Tablet 1 mg

20

30

5

 

 

Tablet 2 mg

20

30

5

 

Cabozantinib

Tablet 20 mg

20

30

2

 

 

 

20

30

5

 

 

Tablet 40 mg

20

30

2

 

 

 

20

30

5

 

 

Tablet 60 mg

20

30

2

 

 

 

20

30

5

 

Calcitonin salmon

Injection 100 I.U. in 1 mL

20

15

5

 

Calcitriol

Capsule 0.25 microgram

20

100

3

 

Calcium

Tablet 600 mg (as carbonate)

20

240

1

 

Candesartan

Tablet containing candesartan cilexetil 4 mg

20

30

5

 

 

Tablet containing candesartan cilexetil 8 mg

20

30

5

 

 

Tablet containing candesartan cilexetil 16 mg

20

30

5

 

 

Tablet containing candesartan cilexetil 32 mg

20

30

5

 

Candesartan with hydrochlorothiazide

Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg

20

30

5

 

 

Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg

20

30

5

 

 

Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg

20

30

5

 

Carbamazepine

Tablet 100 mg

20

200

0

 

 

 

20

200

2

 

 

Tablet 200 mg

20

200

0

 

 

 

20

200

2

 

 

Tablet 200 mg (controlled release)

20

200

0

 

 

 

20

200

2

 

 

Tablet 400 mg (controlled release)

20

200

0

 

 

 

20

200

2

 

Carvedilol

Tablet 6.25 mg

20

60

5

 

 

Tablet 12.5 mg

20

60

5

 

 

Tablet 25 mg

20

60

5

 

Certolizumab pegol

Injection 200 mg in 1 mL single use pre‑filled syringe

20

2

5

 

 

Solution for injection 200 mg in 1 mL pre‑filled pen

20

2

5

 

Citalopram

Tablet 20 mg (as hydrobromide)

20

28

5

 

 

Tablet 40 mg (as hydrobromide)

20

28

5

 

Clonazepam

Tablet 2 mg

20

200

2

 

 

Tablet 500 micrograms

20

200

2

 

Clonidine

Tablet containing clonidine hydrochloride 100 micrograms

20

100

5

 

 

Tablet containing clonidine hydrochloride 150 micrograms

20

100

5

 

Clopidogrel

Tablet 75 mg (as besilate)

20

28

5

 

 

Tablet 75 mg (as hydrogen sulfate)

20

28

5

 

Clopidogrel with aspirin

Tablet 75 mg (as hydrogen sulfate)‑100 mg

20

30

5

 

Dabigatran etexilate

Capsule 75 mg (as mesilate)

20

60

0

 

 

Capsule 110 mg (as mesilate)

20

60

0

 

 

 

20

60

5

 

 

Capsule 150 mg (as mesilate)

20

60

5

 

Dapagliflozin

Tablet 10 mg (as propanediol monohydrate)

20

28

5

 

Dapagliflozin with metformin

Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride

20

56

5

 

 

Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride

20

28

5

 

 

Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride

20

28

5

 

Dapsone

Tablet 25 mg

20

100

1

 

 

Tablet 100 mg

20

100

1

 

Darolutamide

Tablet 300 mg

20

112

5

 

Darunavir with cobicistat, emtricitabine and tenofovir alafenamide

Tablet containing darunavir 800 mg with cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide 10 mg

20

60

5

 

Dasatinib

Tablet 20 mg

20

60

2

 

 

 

20

60

5

 

 

Tablet 50 mg

20

60

2

 

 

 

20

60

5

 

 

Tablet 70 mg

20

60

2

 

 

 

20

60

5

 

 

Tablet 100 mg

20

30

2

 

 

 

20

30

5

 

Decitabine with cedazuridine

Tablet containing decitabine 35 mg with cedazuridine 100 mg

20

5

2

 

 

 

20

5

5

 

Degarelix

Powder for injection 80 mg (as acetate), injection set

20

1

5

 

 

Powder for injection 120 mg (as acetate), 2, injection set

20

1

0

 

Denosumab

Injection 60 mg in 1 mL pre‑filled syringe

20

1

0

 

Desmopressin

Tablet containing desmopressin acetate 200 micrograms

20

30

5

 

 

 

20

90

5

 

 

Wafer 120 micrograms (as acetate)

20

30

5

 

 

Wafer 240 micrograms (as acetate)

20

30

5

 

Desvenlafaxine

Tablet (extended release) 50 mg (as succinate)

20

28

5

 

 

Tablet (extended release) 100 mg (as succinate)

20

28

5

 

 

Tablet (modified release) 50 mg

20

28

5

 

 

Tablet (modified release) 50 mg (as benzoate)

20

28

5

 

 

Tablet (modified release) 100 mg

20

28

5

 

 

Tablet (modified release) 100 mg (as benzoate)

20

28

5

 

Deucravacitinib

Tablet 6 mg

20

28

5

 

Digoxin

Tablet 62.5 micrograms

20

200

1

 

 

Tablet 250 micrograms

20

100

1

 

Diltiazem

Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg

20

30

5

 

 

Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg

20

30

5

 

 

Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg

20

30

5

 

 

Tablet containing diltiazem hydrochloride 60 mg

20

90

5

 

Dimethyl fumarate

Capsule (modified release) 240 mg

20

56

5

 

Diroximel fumarate

Capsule (enteric) 231 mg

20

120

5

 

Dolutegravir with lamivudine

Tablet containing dolutegravir 50 mg (as sodium) with lamivudine 300 mg

20

60

5

 

Dolutegravir with rilpivirine

Tablet containing dolutegravir 50 mg (as sodium) with rilpivirine 25 mg (as hydrochloride)

20

60

5

 

Donepezil

Tablet containing donepezil hydrochloride 5 mg

20

28

5

 

 

Tablet containing donepezil hydrochloride 10 mg

20

28

5

 

Dulaglutide

Injection 1.5 mg in 0.5 mL single dose pre‑filled pen

20

4

5

 

Duloxetine

Capsule 60 mg (as hydrochloride)

20

28

5

 

Dupilumab

Injection 200 mg in 1.14 mL single dose pre‑filled syringe

20

2

5

 

 

Injection 300 mg in 2 mL single dose pre‑filled syringe

20

2

5

 

Dutasteride

Capsule 500 micrograms

20

30

5

 

Dutasteride with tamsulosin

Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms

20

30

5

 

Empagliflozin

Tablet 10 mg

20

30

5

 

 

Tablet 25 mg

20

30

5

 

Empagliflozin with linagliptin

Tablet containing 10 mg empagliflozin with 5 mg linagliptin

20

30

5

 

 

Tablet containing 25 mg empagliflozin with 5 mg linagliptin

20

30

5

 

Empagliflozin with metformin

Tablet containing 5 mg empagliflozin with 500 mg metformin hydrochloride

20

60

5

 

 

Tablet containing 5 mg empagliflozin with 1 g metformin hydrochloride

20

60

5

 

 

Tablet containing 12.5 mg empagliflozin with 500 mg metformin hydrochloride

20

60

5

 

 

Tablet containing 12.5 mg empagliflozin with 1 g metformin hydrochloride

20

60

5

 

Enalapril

Tablet containing enalapril maleate 5 mg

20

30

5

 

 

Tablet containing enalapril maleate 10 mg

20

30

5

 

 

Tablet containing enalapril maleate 20 mg

20

30

5

 

Enalapril with hydrochlorothiazide

Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg

20

30

5

 

Entacapone

Tablet 200 mg

20

200

4

 

Enzalutamide

Capsule 40 mg

20

112

2

 

 

 

20

112

5

 

Eplerenone

Tablet 25 mg

20

30

5

 

 

Tablet 50 mg

20

30

5

 

Eprosartan

Tablet 600 mg (as mesilate)

20

28

5

 

Eprosartan with hydrochlorothiazide

Tablet 600 mg eprosartan (as mesilate) with 12.5 mg hydrochlorothiazide

20

28

5

 

Erlotinib

Tablet 25 mg (as hydrochloride)

20

30

3

 

 

Tablet 100 mg (as hydrochloride)

20

30

3

 

 

Tablet 150 mg (as hydrochloride)

20

30

3

 

Escitalopram

Tablet 10 mg (as oxalate)

20

28

5

 

 

Tablet 20 mg (as oxalate)

20

28

5

 

Esomeprazole

Capsule (enteric) 20 mg (as magnesium)

20

30

1

 

 

 

20

30

5

 

 

 

20

60

5

 

 

Capsule (enteric) 40 mg (as magnesium)

20

30

1

 

 

 

20

30

5

 

 

 

20

60

5

 

 

Tablet (enteric coated) 20 mg (as magnesium trihydrate)

20

30

1

 

 

 

20

30

5

 

 

 

20

60

5

 

 

Tablet (enteric coated) 40 mg (as magnesium trihydrate)

20

30

1

 

 

 

20

30

5

 

 

 

20

60

5

 

Esomeprazole and clarithromycin and amoxicillin

Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate)

20

1

0

 

 

Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate)

20

1

0

 

Estradiol

Tablet 2 mg

20

56

2

 

 

Tablet containing estradiol valerate 1 mg

20

56

2

 

 

Tablet containing estradiol valerate 2 mg

20

56

2

 

 

Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28

20

1

5

 

 

Transdermal patches 390 micrograms, 8

20

1

5

 

 

Transdermal patches 585 micrograms, 8

20

1

5

 

 

Transdermal patches 750 micrograms (as hemihydrate), 8

20

1

5

 

 

Transdermal patches 780 micrograms, 8

20

1

5

 

 

Transdermal patches 1.17 mg, 8

20

1

5

 

 

Transdermal patches 1.5 mg (as hemihydrate), 8

20

1

5

 

 

Transdermal patches 1.56 mg, 8

20

1

5

 

 

Transdermal patches 2 mg, 4

20

1

5

 

 

Transdermal patches 3 mg (as hemihydrate), 8

20

1

5

 

 

Transdermal patches 3.8 mg, 4

20

1

5

 

 

Transdermal patches 5.7 mg, 4

20

1

5

 

 

Transdermal patches 7.6 mg, 4

20

1

5

 

Estradiol and estradiol with dydrogesterone

Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg

20

1

5

 

 

Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg

20

1

5

 

Estradiol and estradiol with norethisterone

Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate

20

1

5

 

 

Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate

20

1

5

 

Estradiol with norethisterone

Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8

20

1

5

 

 

Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8

20

1

5

 

Etanercept

Injection 50 mg in 1 mL single use auto‑injector, 4

20

1

3

 

 

 

20

1

5

 

 

Injection set containing 4 vials powder for injection 25 mg and 4 pre‑filled syringes solvent 1 mL

20

2

3

 

 

 

20

2

5

 

 

Injections 50 mg in 1 mL single use pre‑filled syringes, 4

20

1

3

 

 

 

20

1

5

 

Ethosuximide

Capsule 250 mg

20

200

2

 

Etonogestrel

Subcutaneous implant 68 mg

20

1

0

 

Evolocumab

Injection 140 mg in 1 mL single use pre‑filled pen

20

2

5

 

 

 

20

3

5

 

 

Injection 420 mg in 3.5 mL single use pre‑filled cartridge

20

1

5

 

Ezetimibe

Tablet 10 mg

20

30

5

 

Ezetimibe and rosuvastatin

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium)

20

1

5

 

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium)

20

1

5

 

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium)

20

1

5

 

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium)

20

1

5

 

Ezetimibe with atorvastatin

Tablet 10 mg‑10 mg

20

30

5

 

 

Tablet 10 mg‑20 mg

20

30

5

 

 

Tablet 10 mg‑40 mg

20

30

5

 

 

Tablet 10 mg‑80 mg

20

30

5

 

Ezetimibe with simvastatin

Tablet 10 mg‑10 mg

20

30

5

 

 

Tablet 10 mg‑20 mg

20

30

5

 

 

Tablet 10 mg‑40 mg

20

30

5

 

 

Tablet 10 mg‑80 mg

20

30

5

 

Famciclovir

Tablet 250 mg

20

56

5

 

 

Tablet 500 mg

20

56

5

 

Famotidine

Tablet 20 mg

20

60

5

 

 

Tablet 40 mg

20

30

5

 

Febuxostat

Tablet 80 mg

20

28

5

 

Felodipine

Tablet 2.5 mg (extended release)

20

30

5

 

 

Tablet 5 mg (extended release)

20

30

5

 

 

Tablet 10 mg (extended release)

20

30

5

 

Fenofibrate

Tablet 48 mg

20

60

5

 

 

 

20

60

11

 

 

Tablet 145 mg

20

30

5

 

 

 

20

30

11

 

Fingolimod

Capsule 250 micrograms (as hydrochloride)

20

28

5

 

 

Capsule 500 micrograms (as hydrochloride)

20

28

5

 

Fludarabine

Tablet containing fludarabine phosphate 10 mg

20

20

5

 

Fludrocortisone

Tablet containing fludrocortisone acetate 100 micrograms

20

200

1

 

Flutamide

Tablet 250 mg

20

100

5

 

Fluticasone furoate

Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses

20

1

5

 

 

Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses

20

1

5

 

Fluticasone furoate with umeclidinium and vilanterol

Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses

20

1

5

 

 

Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses

20

1

5

 

Fluvastatin

Tablet (prolonged release) 80 mg (as sodium)

20

28

5

 

 

 

20

28

11

 

Fluvoxamine

Tablet containing fluvoxamine maleate 50 mg

20

30

5

 

 

Tablet containing fluvoxamine maleate 100 mg

20

30

5

 

Folic acid

Tablet 500 micrograms

20

200

0

 

 

Tablet 5 mg

20

200

1

 

Fosinopril

Tablet containing fosinopril sodium 10 mg

20

30

5

 

 

Tablet containing fosinopril sodium 20 mg

20

30

5

 

Fosinopril with hydrochlorothiazide

Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg

20

30

5

 

Fremanezumab

Solution for injection 225 mg in 1.5 mL single dose pre‑filled pen

20

1

2

 

 

 

20

1

5

 

 

Solution for injection 225 mg in 1.5 mL single dose pre‑filled syringe

20

1

2

 

 

 

20

1

5

 

Furosemide

Tablet 20 mg

20

100

1

 

 

Tablet 40 mg

20

100

1

 

Gabapentin

Capsule 100 mg

20

100

5

 

 

Capsule 300 mg

20

100

5

 

 

Capsule 400 mg

20

100

5

 

 

Tablet 600 mg

20

100

5

 

 

Tablet 800 mg

20

100

5

 

Galantamine

Capsule (prolonged release) 8 mg (as hydrobromide)

20

28

5

 

 

Capsule (prolonged release) 16 mg (as hydrobromide)

20

28

5

 

 

Capsule (prolonged release) 24 mg (as hydrobromide)

20

28

5

 

Galcanezumab

Injection 120 mg in 1 mL pre‑filled pen

20

1

5

 

 

 

20

2

1

 

Gemfibrozil

Tablet 600 mg

20

60

5

 

 

 

20

60

11

 

Gliclazide

Tablet 60 mg (modified release)

20

60

5

 

 

Tablet 80 mg

20

100

5

 

Glimepiride

Tablet 3 mg

20

30

5

 

 

Tablet 4 mg

20

30

5

 

Glyceryl trinitrate

Transdermal patch 18 mg

20

30

5

 

 

Transdermal patch 25 mg

20

30

5

 

 

Transdermal patch 36 mg

20

30

5

 

 

Transdermal patch 50 mg

20

30

5

 

 

Transdermal patch 54 mg

20

30

5

 

Glycopyrronium

Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler)

20

30

5

 

Golimumab

Injection 50 mg in 0.5 mL single use pre‑filled pen

20

1

5

 

 

Injection 50 mg in 0.5 mL single use pre‑filled syringe

20

1

5

 

 

Injection 100 mg in 1 mL single use pre‑filled pen

20

1

5

 

Goserelin

Subcutaneous implant 3.6 mg (as acetate) in pre‑filled injection syringe

20

1

5

 

 

Subcutaneous implant (long acting) 10.8 mg (as acetate) in pre‑filled injection syringe

20

1

1

 

Goserelin and bicalutamide

Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg

20

1

5

 

 

Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg

20

1

0

 

 

Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 84 tablets bicalutamide 50 mg

20

1

1

 

Griseofulvin

Tablet 125 mg

20

100

2

 

Guanfacine

Tablet 1 mg (as hydrochloride)

20

28

5

 

 

Tablet 2 mg (as hydrochloride)

20

28

5

 

 

Tablet 3 mg (as hydrochloride)

20

28

5

 

 

Tablet 4 mg (as hydrochloride)

20

28

5

 

Hydrochlorothiazide

Tablet 25 mg

20

100

1

 

Hydrochlorothiazide with amiloride

Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg

20

100

1

 

Hydroxocobalamin

Injection 1 mg (as acetate) in 1 mL

20

3

0

 

 

Injection 1 mg (as chloride) in 1 mL

20

3

0

 

Hydroxychloroquine

Tablet containing hydroxychloroquine sulfate 200 mg

20

100

1

 

Ibandronic acid

Tablet 50 mg (as ibandronate sodium monohydrate)

20

28

2

 

Ibrutinib

Capsule 140 mg

20

90

5

 

 

 

20

120

5

 

 

Tablet 280 mg

20

30

5

 

 

Tablet 420 mg

20

30

5

 

 

Tablet 560 mg

20

30

5

 

Idelalisib

Tablet 100 mg

20

60

5

 

 

Tablet 150 mg

20

60

5

 

Imatinib

Capsule 100 mg (as mesilate)

20

60

2

 

 

 

20

60

5

 

 

Capsule 400 mg (as mesilate)

20

30

2

 

 

 

20

30

5

 

 

Tablet 100 mg (as mesilate)

20

60

2

 

 

 

20

60

5

 

 

Tablet 400 mg (as mesilate)

20

30

2

 

 

 

20

30

5

 

 

Tablet 600 mg (as mesilate)

20

30

2

 

 

 

20

30

5

 

Indacaterol

Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler)

20

30

5

 

 

Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler)

20

30

5

 

Indacaterol with glycopyrronium

Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler)

20

30

5

 

Indacaterol with glycopyrronium and mometasone

Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 136 micrograms (for use in Breezhaler)

20

30

5

 

 

Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 68 micrograms (for use in Breezhaler)

20

30

5

 

Indapamide

Tablet containing indapamide hemihydrate 1.5 mg (sustained release)

20

90

1

 

 

Tablet containing indapamide hemihydrate 2.5 mg

20

90

1

 

Infliximab

Solution for injection 120 mg in 1 mL pre‑filled pen

20

1

0

 

 

 

20

2

0

 

 

 

20

2

2

 

 

 

20

2

5

 

 

Solution for injection 120 mg in 1 mL pre‑filled syringe

20

1

0

 

 

 

20

2

0

 

 

 

20

2

2

 

 

 

20

2

5

 

Insulin aspart

Injection (human analogue) 100 units per mL, 10 mL vial

20

5

2

 

 

Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5

20

5

1

 

 

Injections (human analogue) (fast acting), cartridges, 100 units per mL, 3 mL, 5

20

5

1

 

Insulin aspart with insulin aspart protamine suspension

Injections (human analogue), cartridges, 30 units‑70 units per mL, 3 mL, 5

20

5

1

 

Insulin detemir

Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5

20

5

1

 

Insulin glulisine

Injection (human analogue) 100 units per mL, 10 mL

20

5

2

 

 

Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5

20

5

1

 

Insulin isophane

Injection (human) 100 units per mL, 10 mL

20

5

2

 

 

Injections (human), cartridges, 100 units per mL, 3 mL, 5

20

5

1

 

Insulin lispro

Injection (human analogue) 100 units per mL, 10 mL vial

20

5

2

 

 

Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5

20

5

1

 

 

Injections (human analogue), pre‑filled pen, 200 units per mL, 3 mL, 5

20

5

1

 

Insulin lispro with insulin lispro protamine suspension

Injections (human analogue), cartridges, 25 units‑75 units per mL, 3 mL, 5

20

5

1

 

 

Injections (human analogue), cartridges, 50 units‑50 units per mL, 3 mL, 5

20

5

1

 

Insulin neutral

Injection (human) 100 units per mL, 10 mL

20

5

2

 

 

Injections (human), cartridges, 100 units per mL, 3 mL, 5

20

5

1

 

Insulin neutral with insulin isophane

Injection (human) 30 units‑70 units per mL, 10 mL

20

5

2

 

 

Injections (human), cartridges, 30 units‑70 units per mL, 3 mL, 5

20

5

1

 

 

Injections (human), cartridges, 50 units‑50 units per mL, 3 mL, 5

20

5

1

 

Irbesartan

Tablet 75 mg

20

30

5

 

 

Tablet 150 mg

20

30

5

 

 

Tablet 300 mg

20

30

5

 

Irbesartan with hydrochlorothiazide

Tablet 150 mg‑12.5 mg

20

30

5

 

 

Tablet 300 mg‑12.5 mg

20

30

5

 

 

Tablet 300 mg‑25 mg

20

30

5

 

Isosorbide mononitrate

Tablet 60 mg (sustained release)

20

30

5

 

 

Tablet 120 mg (sustained release)

20

30

5

 

Ivabradine

Tablet 5 mg (as hydrochloride)

20

56

5

 

 

Tablet 7.5 mg (as hydrochloride)

20

56

5

 

Ixekizumab

Injection 80 mg in 1 mL single dose pre‑filled pen

20

2

2

 

Ketoprofen

Capsule 200 mg (sustained release)

20

28

0

 

 

 

20

28

3

 

Labetalol

Tablet containing labetalol hydrochloride 100 mg

20

100

5

 

Lacosamide

Tablet 100 mg

20

56

5

 

 

Tablet 150 mg

20

56

5

 

 

Tablet 200 mg

20

56

5

 

Lamotrigine

Tablet 5 mg

20

56

5

 

 

Tablet 25 mg

20

56

5

 

 

Tablet 50 mg

20

56

5

 

 

Tablet 100 mg

20

56

5

 

 

Tablet 200 mg

20

56

5

 

Lanadelumab

Injection 300 mg in 2 mL single use pre‑filled syringe

20

1

5

 

Lansoprazole

Capsule 15 mg

20

30

5

 

 

Capsule 30 mg

20

28

1

 

 

 

20

28

5

 

 

 

20

56

5

 

 

Tablet 15 mg (orally disintegrating)

20

28

5

 

 

Tablet 30 mg (orally disintegrating)

20

28

1

 

 

 

20

28

5

 

 

 

20

56

5

 

Leflunomide

Tablet 10 mg

20

30

5

 

 

Tablet 20 mg

20

30

5

 

Lercanidipine

Tablet containing lercanidipine hydrochloride 10 mg

20

28

5

 

 

Tablet containing lercanidipine hydrochloride 20 mg

20

28

5

 

Lercanidipine with enalapril

Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg

20

28

5

 

 

Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg

20

28

5

 

Letrozole

Tablet 2.5 mg

20

30

5

 

Leuprorelin

I.M. injection (3 month modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre‑filled dual‑chamber syringe

20

1

1

 

 

I.M. injection (modified release), powder for injection containing leuprorelin acetate 7.5 mg with diluent in pre‑filled dual‑chamber syringe

20

1

5

 

 

I.M. injection (modified release), powder for injection containing leuprorelin acetate 22.5 mg with diluent in pre‑filled dual‑chamber syringe

20

1

1

 

 

I.M. injection (modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre‑filled dual‑chamber syringe

20

1

1

 

 

I.M. injection (modified release), powder for injection containing leuprorelin acetate 45 mg with diluent in pre‑filled dual‑chamber syringe

20

1

0

 

 

Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 7.5 mg, injection set

20

1

5

 

 

Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 22.5 mg, injection set

20

1

1

 

 

Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 30 mg, injection set

20

1

1

 

 

Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 45 mg, injection set

20

1

0

 

Leuprorelin and bicalutamide

Pack containing 1 syringe containing leuprorelin 7.5 mg (as acetate) and 28 tablets bicalutamide 50 mg

20

1

5

 

 

Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 28 tablets bicalutamide 50 mg

20

1

0

 

 

Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 84 tablets bicalutamide 50 mg

20

1

1

 

Levetiracetam

Oral solution 100 mg per mL, 300 mL

20

1

5

 

 

Tablet 250 mg

20

60

5

 

 

Tablet 500 mg

20

60

5

 

 

Tablet 1 g

20

60

5

 

Levodopa with carbidopa and entacapone

Tablet 50 mg‑12.5 mg (as monohydrate)‑200 mg

20

200

4

 

 

Tablet 75 mg‑18.75 mg (as monohydrate)‑200 mg

20

200

4

 

 

Tablet 100 mg‑25 mg (as monohydrate)‑200 mg

20

200

4

 

 

Tablet 125 mg‑31.25 mg (as monohydrate)‑200 mg

20

200

4

 

 

Tablet 150 mg‑37.5 mg (as monohydrate)‑200 mg

20

200

4

 

 

Tablet 200 mg‑50 mg (as monohydrate)‑200 mg

20

200

4

 

Levonorgestrel

Intrauterine drug delivery system 19.5 mg

20

1

0

 

 

Intrauterine drug delivery system 52 mg

20

1

0

 

 

Tablets 30 micrograms, 28

20

4

2

 

Levonorgestrel with ethinylestradiol

Pack containing 6 tablets 50 micrograms‑30 micrograms, 5 tablets 75 micrograms‑40 micrograms, 10 tablets 125 micrograms‑30 micrograms and 7 inert tablets

20

4

2

 

 

Pack containing 21 tablets 100 micrograms‑20 micrograms and 7 inert tablets

20

4

2

 

 

Pack containing 21 tablets 125 micrograms‑50 micrograms and 7 inert tablets

20

4

2

 

 

Pack containing 21 tablets 150 micrograms‑30 micrograms and 7 inert tablets

20

4

2

 

Levothyroxine

Tablet containing 50 micrograms anhydrous levothyroxine sodium

20

200

1

 

 

Tablet containing 75 micrograms anhydrous levothyroxine sodium

20

200

1

 

 

Tablet containing 100 micrograms anhydrous levothyroxine sodium

20

200

1

 

 

Tablet containing 125 micrograms anhydrous levothyroxine sodium

20

200

1

 

 

Tablet containing 200 micrograms anhydrous levothyroxine sodium

20

200

1

 

Linagliptin

Tablet 5 mg

20

30

5

 

Linagliptin with metformin

Tablet containing 2.5 mg linagliptin with 500 mg metformin hydrochloride

20

60

5

 

 

Tablet containing 2.5 mg linagliptin with 850 mg metformin hydrochloride

20

60

5

 

 

Tablet containing 2.5 mg linagliptin with 1000 mg metformin hydrochloride

20

60

5

 

Liothyronine

Tablet containing liothyronine sodium 20 micrograms

20

100

2

 

Lisinopril

Tablet 5 mg

20

30

5

 

 

Tablet 10 mg

20

30

5

 

 

Tablet 20 mg

20

30

5

 

Medroxyprogesterone

Injection containing medroxyprogesterone acetate 150 mg in 1 mL

20

1

1

 

 

Tablet containing medroxyprogesterone acetate 5 mg

20

56

2

 

 

Tablet containing medroxyprogesterone acetate 10 mg

20

30

2

 

 

 

20

100

2

 

Meloxicam

Capsule 15 mg

20

30

3

 

 

Tablet 15 mg

20

30

3

 

Memantine

Tablet containing memantine hydrochloride 10 mg

20

56

5

 

 

Tablet containing memantine hydrochloride 20 mg

20

28

5

 

Mesalazine

Sachet containing granules, 500 mg per sachet

20

200

5

 

 

Sachet containing granules, 1 g per sachet

20

100

5

 

 

Sachet containing granules, 1.5 g per sachet

20

60

5

 

 

Sachet containing granules, 3 g per sachet

20

30

5

 

 

Sachet containing prolonged release granules, 1 g per sachet

20

100

5

 

 

Sachet containing prolonged release granules, 2 g per sachet

20

60

5

 

 

Sachet containing prolonged release granules, 4 g per sachet

20

30

5

 

 

Tablet 250 mg (enteric coated)

20

100

5

 

 

Tablet 500 mg (enteric coated)

20

200

5

 

 

Tablet 500 mg (prolonged release)

20

200

5

 

 

Tablet 800 mg (enteric coated)

20

90

5

 

 

Tablet 1 g (enteric coated)

20

120

5

 

 

Tablet 1 g (prolonged release)

20

120

5

 

 

Tablet 1.2 g (prolonged release)

20

120

5

 

 

Tablet 1.6 g (enteric coated)

20

120

4

 

Metformin

Tablet containing metformin hydrochloride 500 mg

20

100

5

 

 

Tablet containing metformin hydrochloride 850 mg

20

60

5

 

 

Tablet containing metformin hydrochloride 1 g

20

90

5

 

 

Tablet (extended release) containing metformin hydrochloride 500 mg

20

120

5

 

 

Tablet (extended release) containing metformin hydrochloride 1 g

20

60

5

 

Methadone

Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 1 L bottle, 1 mL

20

840

2

 

 

Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 200 mL bottle, 1 mL

20

840

2

 

Methotrexate

Injection 7.5 mg in 0.15 mL pre‑filled syringe

20

4

5

 

 

Injection 10 mg in 0.2 mL pre‑filled syringe

20

4

5

 

 

Injection 15 mg in 0.3 mL pre‑filled syringe

20

4

5

 

 

Injection 20 mg in 0.4 mL pre‑filled syringe

20

4

5

 

 

Injection 25 mg in 0.5 mL pre‑filled syringe

20

4

5

 

Methyldopa

Tablet 250 mg (as sesquihydrate)

20

100

5

 

Methylprednisolone

Injection containing methylprednisolone acetate 40 mg in 1 mL

20

5

0

 

Metoprolol

Tablet containing metoprolol tartrate 50 mg

20

100

5

 

 

Tablet containing metoprolol tartrate 100 mg

20

60

5

 

Metoprolol succinate

Tablet 47.5 mg (controlled release)

20

30

5

 

 

Tablet 95 mg (controlled release)

20

30

5

 

 

Tablet 190 mg (controlled release)

20

30

5

 

Minocycline

Tablet 50 mg (as hydrochloride)

20

60

5

 

Minoxidil

Tablet 10 mg

20

100

5

 

 

Tablet 10 mg (s19A)

20

100

5

 

Mirtazapine

Tablet 45 mg

20

30

5

 

 

Tablet 45 mg (orally disintegrating)

20

30

5

 

Moclobemide

Tablet 150 mg

20

60

5

 

 

Tablet 300 mg

20

60

5

 

Modafinil

Tablet 100 mg

20

120

5

 

Montelukast

Tablet, chewable, 4 mg (as sodium)

20

28

5

 

 

Tablet, chewable, 5 mg (as sodium)

20

28

5

 

Moxonidine

Tablet 200 micrograms

20

30

5

 

 

Tablet 400 micrograms

20

30

5

 

Nafarelin

Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses

20

1

5

 

Naproxen

Tablet 750 mg (sustained release)

20

28

0

 

 

 

20

28

3

 

 

Tablet 1 g (sustained release)

20

28

0

 

 

 

20

28

3

 

Nebivolol

Tablet 1.25 mg (as hydrochloride)

20

56

5

 

 

Tablet 5 mg (as hydrochloride)

20

28

5

 

 

Tablet 10 mg (as hydrochloride)

20

28

5

 

Nicorandil

Tablets 10 mg, 60

20

1

5

 

 

Tablets 20 mg, 60

20

1

5

 

Nifedipine

Tablet 30 mg (controlled release)

20

30

5

 

 

Tablet 60 mg (controlled release)

20

30

5

 

Nilotinib

Capsule 150 mg (as hydrochloride monohydrate)

20

120

5

 

 

Capsule 200 mg (as hydrochloride monohydrate)

20

120

5

 

Nintedanib

Capsule 100 mg

20

60

5

 

 

Capsule 150 mg

20

60

5

 

Niraparib

Capsule 100 mg (as tosilate monohydrate)

20

56

2

 

 

 

20

56

5

 

 

 

20

84

2

 

 

 

20

84

5

 

Nizatidine

Capsule 150 mg

20

60

5

 

 

Capsule 300 mg

20

30

5

 

Norethisterone

Tablets 350 micrograms, 28

20

4

2

 

Norethisterone with ethinylestradiol

Pack containing 21 tablets 500 micrograms‑35 micrograms and 7 inert tablets

20

4

2

 

 

Pack containing 21 tablets 1 mg‑35 micrograms and 7 inert tablets

20

4

2

 

Obeticholic acid

Tablet 5 mg

20

30

5

 

 

Tablet 10 mg

20

30

5

 

Ofatumumab

Solution for injection 20 mg in 0.4 mL pre‑filled pen

20

1

5

 

 

 

20

3

0

 

Olaparib

Tablet 100 mg

20

112

5

 

 

Tablet 150 mg

20

112

5

 

Olmesartan

Tablet containing olmesartan medoxomil 20 mg

20

30

5

 

 

Tablet containing olmesartan medoxomil 40 mg

20

30

5

 

Olmesartan with amlodipine

Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate)

20

30

5

 

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate)

20

30

5

 

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate)

20

30

5

 

Olmesartan with amlodipine and hydrochlorothiazide

Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg

20

30

5

 

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg

20

30

5

 

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg

20

30

5

 

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg

20

30

5

 

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg

20

30

5

 

Olmesartan with hydrochlorothiazide

Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg

20

30

5

 

 

Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg

20

30

5

 

 

Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg

20

30

5

 

Olsalazine

Capsule containing olsalazine sodium 250 mg

20

100

5

 

 

Tablet containing olsalazine sodium 500 mg

20

100

5

 

Omeprazole

Capsule 20 mg

20

30

1

 

 

 

20

30

5

 

 

 

20

60

5

 

 

Tablet 10 mg (as magnesium)

20

30

5

 

 

Tablet 20 mg

20

30

1

 

 

 

20

30

5

 

 

 

20

60

5

 

 

Tablet 20 mg (as magnesium)

20

30

1

 

 

 

20

30

5

 

 

 

20

60

5

 

Opicapone

Capsule 50 mg

20

30

5

 

Oxcarbazepine

Tablet 600 mg

20

100

5

 

Oxprenolol

Tablet containing oxprenolol hydrochloride 40 mg

20

100

5